Therapeutic Goods (Poisons Standard) (Benzylpenicillin - Seqirus) Exemption 2022
Published
Related content
-
Therapeutic Goods (Poisons Standard) (Benzylpenicillin—Seqirus) Approval 2024
This instrument is the Therapeutic Goods (Poisons Standard) (Benzylpenicillin—Seqirus) Approval 2024. -
Therapeutic Goods (Poisons Standard) (COVID-19 Treatment - Gilead) (Remdesivir) Labelling Exemption 2021
This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard. -
Therapeutic Goods (Poisons Standard) (COVID-19 Treatment - Pfizer) (Nirmatrelvir and Ritonavir) Labelling Exemption 2022
This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.